Navigation path

NEAT


HIV/AIDS

The European AIDS Treatment Network
Framework programme:
6
Call:
4
Project number:
LSHP-CT-2006-037570
EC contribution:
€ 12,500,000
Duration:
60 Months
Type:
NoE
Starting date:
1st February 2007

Keywords: HIV, AIDS, Antiretroviral Therapy, Clinical Research, Europe, Networking, Research and Spreading

Summary:

NEAT’s mission is to strengthen European HIV clinical research capacity by building a clinical and laboratory network in HIV therapeutics. NEAT will catalyse a critical mass of resources and expertise, with the direct involvement of 41 core partners from 16 countries and over 350 affiliated centres of established international reputation. NEAT is committed to designing the roadmap for a durable reshaping of the way clinical research is carried out in Europe so as to achieve a progressive and lasting integration. In doing so, NEAT will pave the way toward the creation of the European Research Area.

The Network will also spread expertise and resources provide training and mobility of scientists at all levels and will foster lasting collaborations across Europe.

Background:

Academic and publicly driven transnational and clinical research in Europe is still fragmented and insufficiently funded, despite some relevant examples of at least partial integration and coordination (e.g. cancer and cardiovascular research). In fact, the majority of preclinical and phase I-III clinical research is carried out by the pharmaceutical industry. In the HIV infection and AIDS area, public investments and coordination varies considerably from country to country, with only a few countries having specific National Programmes providing funding, and/or Central Coordinating Institutions providing technical support to clinical research within the country.

Combination antiretroviral therapy has resulted in a dramatic decrease in mortality and HIV-associated morbidity in industrialised countries. Nevertheless, many serious issues and challenges – namely long term toxicity and HIV drug resistance - are problematic and important in the management of HIV infected individuals, even when treated according to the state-of-the-art. The need for further advances in clinical governance and management of HIV infection remains a high priority, both from a public health and from a medical research perspective.

[+] Read More